An evidence-based disease-management program for patients with diabetic nephropathy

Journal of Nephrology

Volumn 16, Issue 4, 2003, Pages 500-510

  Gandjour, Afschin ^a   Lauterbach, Karl Wilhelm ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Diabetic nephropathy; End stage renal disease; Systematic reviews

Indexed keywords

CLINICAL TRIAL; COST UTILITY ANALYSIS; DIABETIC NEPHROPATHY; DIALYSIS; DOCTOR PATIENT RELATION; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HUMAN; KIDNEY FAILURE; MANAGER; MEDICAL EDUCATION; MEDICAL RESEARCH; OUTCOMES RESEARCH; PATIENT CARE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; REVIEW;

AMBULATORY CARE; COMBINED MODALITY THERAPY; DIABETIC NEPHROPATHIES; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; FEMALE; GERMANY; HOSPITALS; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; PROGRAM DEVELOPMENT; PROGRAM EVALUATION;

EID: 1642494865     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Lauterbach KW, Stock S, Redaèlli M, Kühn M, Lüngen M. Disease Management in Deutschland: Voraussetzungren, Rahmenbedingungen, Faktoren zur Entwicklung, Implementierung und Evaluation. Report. Köln: Institut für Gesundheitsökonomie und Klinische Epidemiologie 2001; 21-3.
2. Rosenberg W, Donald A. Evidence based medicine: An approach to clinical problem-solving. Br Med J 1995; 310: 1122-6.
3. Weber M, Marx M. Wird Dialyse unbezahlbar - Netzwerkstrategien zur Verbesserung der Frühdiagnostik von Nierenerkrankungen. 105. Kongress der Deutschen Gesellschaft für Innere Medizin. Satelliten-Symposium. Wiesbaden: 1999 Apr 11. http://www.thieme.de/dmw/index.html? fr_nav_home. htm&fr_blue.htm&http://www.thieme.de/dmw/dgim/inhalt/zusfass/uebers.htm (accessed 14 November 2001).
4. Keller C, Ritz E, Pommer W, Stein G, Frank J, Schwarzbeck A. The quality of the treatment of diabetics in kidney failure in Germany. Dtsch Med Wochenschr 2000; 125: 240-4.
5. RMS Disease Management Inc. http://www.rmshealthsystems.com/ (accessed 7 October 2002).
6. Optimal Renal Care. http://www.optimalrenalcare.com/ (accessed 7 October 2002).
7. QuaSi-Niere. Bericht 1999. http://wwww.quasi-niere.de/ (accessed 16 November 2001).
8. Center for Evidence-Based Medicine. http://cebm.jr2.ox.ac.uk/docs/searching.html (accessed on November 4, 2001).
9. Gandjour A, Kleinschmit F, Littmann V, Lauterbach KW. An evidence-based evaluation of quality and efficiency indicators. Qual Manag Health Care 2002; 10: 41-52.
10. Agency for Health Care Policy and Research. Acute Pain Management: Operative and Medical Procedures and Trauma. Rockville: AHCPR 1992.
11. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol 1991; 44: 1271-8.
12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomised clinical trials: Is binding necessary? Control Clin Trials 1996; 17: 1-12.
13. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994; 271: 1615-9.
14. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 271: 703-7.
15. Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1994; 271: 389-91.
16. Burnand B, Kernan WN, Feinstein AR. Indexes and boundaries for "quantitative significance" in statistical decisions. J Clin Epidemiol 1990; 43: 1273-84.
17. Piehlmeier W, Renner R, Schramm W, Schneider A, König A, Gottsmann M, Hardenberg R, Von Hübbenet JE. PROSIT® - A quality management system for diabetic patients with nephropathy in Germany. DNM 2000; 14: 110-4.
18. Harris LE, Luft FC, Rudy DW, Kesterson JG, Tierney WM. Effects of multidisciplinary case management in patients with chronic renal insufficiency. Am J Med 1998; 105: 464-71.
19. Binik YM, Devins GM, Barre PE, Guttmann RD, Hollomby DJ, Mandin H, Paul LC, Hons RB, Burgess ED. Live and learn: Patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis 1993; 181: 371-6.
20. Ifudu O, Dawood M, Homel P, Friedman EA. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 1996; 28: 841-5.
21. Arora P, Kausz AT, Obrador GT, Ruthazer R, Khan S, Jenuleson CS, Meyer KB, Pereira BJ. Hospital utilisation among chronic dialysis patients. J Am Soc Nephrol 2000; 11: 740-6.
22. Jungers P, Zingraff J, Albouze G, Chauveau P, Page B, Hannedouche T, Man NK. Late referral to maintenance dialysis: Detrimental consequences. Nephrol Dial Transplant 1993; 8: 1089-93.
23. Tawney KW, Tawney PJ, Hladik G, Hogan SL, Falk RJ, Weaver C, Moore DT, Lee MY. The life readiness program: A physical rehabilitation program for patients on hemodialysis. Am J Kidney Dis 2000; 36: 581-91.
24. Ramsay CR, Campbell MK, Cantarovich D, Catto G, Cody J, Daly C, Delcroix C, Edward N, Grimshaw JM, Van Hamersvelt HW, Henderson IS, Khan IH, Koene RA, Papadimitrou M, Ritz E, Tsakiris D, MacLeod AM. Evaluation of clinical guidelines for the management of end-stage renal disease in Europe: The EU BIOMED 1 study. Nephrol Dial Transplant 2000; 15: 1394-8.
25. Nissenson AR, Collins AJ, Dickmeyer J, Litchfield T, Mattern W, McMahill CN, Muhlbaier L, Nielsen J, Owen WF Jr, Pereira BJ, Steinman TI, Szczech L. Evaluation of disease-state management of dialysis patients. Am J Kidney Dis 2001; 37: 938-44.
26. Korniewicz DM, O'Brien ME. Evaluation of a hemodialysis patient education and support program. Anna J 1994; 21: 33-8.
27. Hasslacher C, Gandjour A, Redaèlli M, Bretzel RG, Danne D, Ritz E, Sawicki P, Walter H. Diagnose, Therapie und Verlaufskontrolle der diabetischen Nephropathie: In Scherbaum WA, Lauterbach KW, Renner R Eds: Evidenzbasierte Diabetes-Leitlinien. Deutsche Diabetes Gesellschaft. Düsseldorf: DDG 2000.
28. Scottish Intercollegiate Guidelines Network: Management of Diabetes. Edinburgh: SIGN 2001.
29. National Kidney Foundation. K/DOQI Clinical Practice Guidelines. http://www.kidney.org/professionals/doqi/index.cfm (accessed 10 November 2001).
30. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: A systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995; 153: 1423-31.
31. Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: Do conferences, workshops, rounds, and other traditional continuing education activities change physician behaviour or health care outcomes? JAMA 1999; 282: 867-74.
32. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983; 32 (suppl 2): S64-78.
33. American Diabetes Association. Clinical Practice Recommendations 2001. Diabetes Care 2001; 24 (suppl 1): S1-133.
34. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993; 341: 1306-9.
35. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703-13.
36. Couper JJ, Staples AJ, Cocciolone R, Nairn J, Badcock N, Henning P. Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabet Med 1994; 11: 666-9.
37. Faronato PP, Maioli M, Tonolo G, Brocco E, Noventa F, Piarulli F, Abaterusso C, Modena F, De Bigontina G, Velussi M, Inchiostro S, Santeusanio F, Bueti A, Nosadini R. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia 1997; 40: 816-23.
38. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 1996; 19: 195-203.
39. NIH Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: An NIH consensus conference statement. Ann Intern Med 1994; 121: 62-70.
40. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994; 3: 329-38.
41. Gandjour A, Westenhofer J, Wirth A, Fuchs C, Lauterbach KW. Development process of an evidence-based guideline for the treatment of obesity. Int J Qual Health Care 2001; 13: 325-32.